brontictuzumab

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center, OncoMed Pharmaceuticals, Inc.

Conditions

Adenoid Cystic CarcinomaMetastatic Colorectal Cancer

Phase 1

A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer

CompletedNCT03031691

OncoMed Pharmaceuticals, Inc.Metastatic Colorectal Cancer

Start: 2017-01-31End: 2017-09-30Updated: 2020-08-11

Unknown Phase

Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC)

CompletedNCT02662608

M.D. Anderson Cancer CenterAdenoid Cystic Carcinoma

Start: 2015-12-29End: 2016-03-06Updated: 2017-06-14